Search Browse Earnings

Acurx Pharmaceuticals, Inc. — SlamSEC

Acurx Pharmaceuticals, Inc.

Nasdaq:ACXP

Pharmaceutical Preparations·STATEN ISLAND, NY

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

—

Adj. EBITDA

—

Net Income

-$14.6M

FY 2024

EPS (Diluted)

-$1.15

FY 2024

Stock Price

$1.78

+24.0%

2026-03-09

52W Range

$1.33 – $21.00

P/E Ratio

-1.5x

Market Cap

$3.7M

Cash

$7.5M

FY 2024

Total Debt

—

Net Cash

$7.5M

Enterprise Value

-$3.8M

Debt / EBITDA

—

EV / EBITDA

—

Employees

—

CEO

Luci David P

CFO

Shawah Robert G.